Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BIND Therapeutics Inc (NASDAQ:BIND)

4.84
Delayed Data
As of 11:30am ET
 +0.1107 / +2.34%
Today’s Change
4.06
Today|||52-Week Range
10.78
-10.36%
Year-to-Date

Today’s Trading

Previous close4.73
Today’s open4.79
Day’s range4.67 - 4.85
Volume22,525
Average volume (3 months)133,008
Market cap$98.1M
Dividend yield--
Data as of 11:30am ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)+62.04%
Earnings growth (this year)+6.77%
Earnings growth (next 5 years)--
Revenue growth (last year)-4.36%
P/E ratioNM
Price/Sales8.54
Price/Book2.11

Competitors

 Today’s
change
Today’s
% change
ADMAADMA Biologics Inc-0.02-0.22%
PIPPharmAthene Inc-0.07-4.73%
TENXTenax Therapeutics I...+0.12+3.66%
BPTHBio Path Holdings In...+0.03+2.54%
Data as of 11:32am ET, 09/02/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)-$0.48
Annual revenue (last year)$10.4M
Annual profit (last year)-$32.5M
Net profit margin-312.08%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Andrew J. Hirsch
Secretary, Treasurer &
Senior VP-Finance
Christopher M. Lindblom
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers